China Biologic Products, Inc. (CBPO) Tops Q1 EPS by 5c, Revenues Beat Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq ease from record highs as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts CBPO Hot Sheet
Join SI Premium – FREE
China Biologic Products, Inc. (NASDAQ: CBPO) reported Q1 non-GAAP EPS of $0.31, $0.05 better than the analyst estimate of $0.26. Revenue for the quarter came in at $34.5 million versus the consensus estimate of $29.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Taylor Devices (TAYD) Misses Q1 EPS by 79c
- Cal-Maine Foods stock edges down on first quarter loss and revenue miss
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
